Basic Information
RNALocate ID: RLID:11003121
RNA Symbol: hsa-miR-503-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-503-5p
RNA ID: miRBase:MIMAT0002874
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002358 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002359 Mitochondrion Myotube 27396686
RLID:01002360 Mitochondrion Skeletal muscle cells 27563705
RLID:01002361 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002362 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:11003117 Exosome Human umbilical vein endothelial cells 25860935
RLID:11003118 Exosome Serum 18589210
RLID:11003119 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11003120 Exosome Brain tissue 23382797
RLID:11003122 Exosome Human mast cell line (HMC-1) 24009880
RLID:11003123 Microvesicle Follicular fluid 23666971
RLID-D:11000497 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
RLID-D:11001301 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-503-5p Oral squamous cell carcinoma MNDR-E-MI-55769
MNDR hsa-miR-503-5p High-grade serous ovarian carcinoma MNDR-E-MI-55770
MNDR hsa-miR-503-5p Uterine corpus endometrial carcinoma MNDR-E-MI-55771
MNDR hsa-miR-503-5p Lymphoma MNDR-E-MI-55772
MNDR hsa-miR-503-5p Estrogen-receptor positive breast cancer MNDR-E-MI-55773
MNDR hsa-miR-503-5p Estrogen-receptor negative breast cancer MNDR-E-MI-55774
MNDR hsa-miR-503-5p Progesterone-receptor positive breast cancer MNDR-E-MI-55775
MNDR hsa-miR-503-5p Progesterone-receptor negative breast cancer MNDR-E-MI-55776
MNDR hsa-miR-503-5p Breast cancer luminal MNDR-E-MI-55777
MNDR hsa-miR-503-5p Dermatomyositis MNDR-E-MI-55778
MNDR hsa-miR-503-5p Prostate cancer MNDR-E-MI-55779
MNDR hsa-miR-503-5p Gastric cancer MNDR-E-MI-55780
MNDR hsa-miR-503-5p Esophageal carcinoma MNDR-E-MI-55781
MNDR hsa-miR-503-5p Dysautonomia familial MNDR-E-MI-55782
MNDR hsa-miR-503-5p Seizures MNDR-E-MI-55783
MNDR hsa-miR-503-5p Head and neck cancer MNDR-E-MI-55784
MNDR hsa-miR-503-5p Leukemia MNDR-E-MI-55785
MNDR hsa-miR-503-5p Cardiovascular disease MNDR-E-MI-55786
MNDR hsa-miR-503-5p Lung cancer MNDR-E-MI-55787
MNDR hsa-miR-503-5p Parkinson disease MNDR-E-MI-55788
MNDR hsa-miR-503-5p Basal-like breast cancer MNDR-E-MI-55789
MNDR hsa-miR-503-5p Neuroendocrine neoplasia MNDR-E-MI-55790
MNDR hsa-miR-503-5p Squamous cell carcinoma MNDR-E-MI-55791
MNDR hsa-miR-503-5p Pituitary neoplasms MNDR-E-MI-55792
MNDR hsa-miR-503-5p Pancreatic cancer MNDR-E-MI-55793
MNDR hsa-miR-503-5p Melanoma MNDR-E-MI-55794
MNDR hsa-miR-503-5p Rectum adenocarcinoma MNDR-E-MI-55795
MNDR hsa-miR-503-5p Nephroblastoma MNDR-E-MI-55796
MNDR hsa-miR-503-5p Colon cancer MNDR-E-MI-55797
MNDR hsa-miR-503-5p Colon adenocarcinoma MNDR-E-MI-55798
MNDR hsa-miR-503-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-55799
MNDR hsa-miR-503-5p Acromegaly MNDR-E-MI-55800
MNDR hsa-miR-503-5p Prostate adenocarcinoma MNDR-E-MI-55801
MNDR hsa-miR-503-5p Adenocarcinoma MNDR-E-MI-55802
MNDR hsa-miR-503-5p Carcinoma ductal breast MNDR-E-MI-55803
MNDR hsa-miR-503-5p Glioblastoma MNDR-E-MI-55804
MNDR hsa-miR-503-5p Astrocytoma MNDR-E-MI-55805
MNDR hsa-miR-503-5p Glioma MNDR-E-MI-55806
MNDR hsa-miR-503-5p Amyotrophic lateral sclerosis MNDR-E-MI-55807
MNDR hsa-miR-503-5p Osteosarcoma MNDR-E-MI-55808
MNDR hsa-miR-503-5p Breast carcinoma MNDR-E-MI-55809
MNDR hsa-miR-503-5p Infarction middle cerebral artery MNDR-E-MI-55810
MNDR hsa-miR-503-5p Gastric adenocarcinoma MNDR-E-MI-55811
MNDR hsa-miR-503-5p Pituitary adenoma MNDR-E-MI-55812
MNDR hsa-miR-503-5p Lung squamous cell carcinoma MNDR-E-MI-55813
MNDR hsa-miR-503-5p Lung adenocarcinoma MNDR-E-MI-55814
MNDR hsa-miR-503-5p Adrenocortical cancer MNDR-E-MI-55815
MNDR hsa-miR-503-5p Thyroid carcinoma MNDR-E-MI-55816
MNDR hsa-miR-503-5p Ovarian carcinoma MNDR-E-MI-55817
MNDR hsa-miR-503-5p Bladder urothelial carcinoma MNDR-E-MI-55818
MNDR hsa-miR-503-5p Pancreatic adenocarcinoma MNDR-E-MI-55819
MNDR hsa-miR-503-5p Kidney renal papillary cell carcinoma MNDR-E-MI-55820
MNDR hsa-miR-503-5p Clear cell renal cell carcinoma MNDR-E-MI-55821
MNDR hsa-miR-503-5p Esophageal cancer MNDR-E-MI-55822
MNDR hsa-miR-503-5p Synovial sarcoma MNDR-E-MI-55823
MNDR hsa-miR-503-5p Head and neck squamous cell carcinoma MNDR-E-MI-55824
MNDR hsa-miR-503-5p Growth hormone-secreting pituitary adenoma MNDR-E-MI-55825
MNDR hsa-miR-503-5p Breast invasive carcinoma MNDR-E-MI-55826
MNDR hsa-miR-503-5p Hepatocellular carcinoma MNDR-E-MI-55827
MNDR hsa-miR-503-5p Retinoblastoma MNDR-E-MI-55828
MNDR hsa-miR-503-5p Tonsil cancer MNDR-E-MI-55829
MNDR hsa-miR-503-5p Neuromyelitis optica MNDR-E-MI-55830
MNDR hsa-miR-503-5p Colorectal cancer MNDR-E-MI-55831
MNDR hsa-miR-503-5p Nasopharynx carcinoma MNDR-E-MI-55832
MNDR hsa-miR-503-5p Nasopharyngeal cancer MNDR-E-MI-55833
MNDR hsa-miR-503-5p Chronic pain MNDR-E-MI-55834
MNDR hsa-miR-503-5p Stroke lacunar MNDR-E-MI-55835
MNDR hsa-miR-503-5p Duke A MNDR-E-MI-55836
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AGO1 Homo sapiens RR00055430
TOP